Literature DB >> 9131538

Pharmacokinetics of enrofloxacin in the red pacu (Colossoma brachypomum) after intramuscular, oral and bath administration.

G Lewbart1, S Vaden, J Deen, C Manaugh, D Whitt, A Doi, T Smith, K Flammer.   

Abstract

The intramuscular (i.m.), oral (p.o.), and bath immersion disposition of enrofloxacin were evaluated following administration to a cultured population of red pacu. The half-life for enrofloxacin following i.m. administration was 28.9 h, considerably longer than values calculated for other animals such as dogs, birds, rabbits, and tortoises. The 4 h maximum concentration (Cmax) of 1.64 micrograms/ml, following a single 5.0 mg/kg dosing easily exceeds the in vitro minimum inhibitory concentration (MIC) for 20 bacterial organisms known to infect fish. At 48 h post i.m. administration, the mean plasma enrofloxacin concentration was well above the MIC for most gram-negative fish pathogens. The gavage method of oral enrofloxacin administration produced a Cmax of 0.94 microgram/mL at 6-8 h. This Cmax was well above the reported in vitro MIC. A bath immersion concentration of 2.5 mg/L for 5 h was used in this study. The Cmax of 0.17 microgram/mL was noted on the 2 hour post-treatment plasma sample. Plasma concentrations of enrofloxacin exceeded published in vitro MIC's for most fish bacterial pathogens 72 h after treatment was concluded. Ciprofloxacin, an active metabolite of enrofloxacin, was detected and measured after all methods of drug administration. It is possible and practical to obtain therapeutic blood concentrations of enrofloxacin in the red pacu using p.o., i.m., and bath immersion administration. The i.m. route is the most predictable and results in the highest plasma concentrations of the drug.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131538     DOI: 10.1046/j.1365-2885.1997.00814.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  7 in total

Review 1.  Application of veterinary antibiotics in China's aquaculture industry and their potential human health risks.

Authors:  Wing Yin Mo; Zhanting Chen; Ho Man Leung; Anna Oi Wah Leung
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-26       Impact factor: 4.223

2.  Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China.

Authors:  Xiuting He; Zhaohui Wang; Xiangping Nie; Yufen Yang; Debo Pan; Anna O W Leung; Zhang Cheng; Yongtao Yang; Kaibin Li; Kunci Chen
Journal:  Environ Geochem Health       Date:  2011-09-01       Impact factor: 4.609

3.  The pharmacokinetics of enrofloxacin in adult African clawed frogs (Xenopus laevis).

Authors:  Antwain M Howard; Mark G Papich; Stephen A Felt; Charles T Long; Gabriel P McKeon; Emmitt S Bond; Stéphanie L Torreilles; Richard H Luong; Sherril L Green
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

4.  Enrofloxacin Pharmacokinetics and Sampling Techniques in California Sea Hares (Aplysia californica).

Authors:  Sharon E Mason; Mark G Papich; Michael C Schmale; Craig A Harms; Sally A Davis
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-02-28       Impact factor: 1.232

5.  Long depletion time of enrofloxacin in rainbow trout (Oncorhynchus mykiss).

Authors:  Dario Lucchetti; Laura Fabrizi; Emilio Guandalini; Elisabetta Podestà; Luigi Marvasi; Anna Zaghini; Ettore Coni
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Pharmacokinetics and Tissue Distribution of Enrofloxacin Following Single Oral Administration in Yellow River Carp (Cyprinus carpio haematoperus).

Authors:  Fan Yang; Chao-Shuo Zhang; Ming-Hui Duan; Han Wang; Zhe-Wen Song; Hao-Tian Shao; Kai-Li Ma; Fang Yang
Journal:  Front Vet Sci       Date:  2022-02-04

7.  Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Crucian Carp (Carassius auratus gibelio) Following Single and Multiple Oral Administration.

Authors:  Qi Shan; Heqing Huang; Guangming Zheng; Yi Yin; Xinping Zhu; Lisha Ma; Hao Zhou; Wenping Xie; Lichun Li; Shugui Liu; Jingxin Wang
Journal:  Front Vet Sci       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.